kanamycin a has been researched along with Disease Models, Animal in 91 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (27.47) | 18.7374 |
| 1990's | 11 (12.09) | 18.2507 |
| 2000's | 10 (10.99) | 29.6817 |
| 2010's | 42 (46.15) | 24.3611 |
| 2020's | 3 (3.30) | 2.80 |
| Authors | Studies |
|---|---|
| Brantner, A; Brun, R; Bucar, F; Faist, J; Gröblacher, B; Kaiser, M; Kalia, Y; Merino, V; Perozzo, R; Saf, R; Scapozza, L; Seebacher, W; Weis, R; Wolkinger, V | 1 |
| Alobaidallah, MSA; Andersen, TE; García, V; Grønnemose, RB; Guerra, PR; Herrero-Fresno, A; Olsen, JE; Stærk, K | 1 |
| Ahrens, D; Bankstahl, JP; Behrends, W; Esser, KH; Lenarz, T; Paasche, G; Scheper, V | 1 |
| Klis, SFL; Ramekers, D; Versnel, H | 1 |
| Kaur, T; Ohlemiller, KK; Warchol, ME | 1 |
| Bermúdez-Muñoz, JM; García-Alcántara, F; Martínez-Vega, R; Milo, M; Murillo-Cuesta, S; Pulido, S; Rivera, T; Varela-Nieto, I | 1 |
| Jung, G; Kim, SY; Koo, JW; Shim, YJ | 1 |
| Takasu, K; Tateno, T | 1 |
| Deng, X; Hu, Z; Li, X; Liu, Z; Zhou, Y | 1 |
| Bremer, HG; Grolman, W; Hendriksen, FG; Jansen, TT; Klis, SF; Topsakal, V | 1 |
| Grolman, W; Havenith, S; Klis, SF; Versnel, H | 2 |
| Duan, M; Jing, Y; Wei, J; Zheng, G; Zhu, K; Zhu, Z | 1 |
| Johnson, SB; Santi, PA; Schmitz, HM | 1 |
| Fernandes, VT; Lin, VY | 1 |
| Hirose, K; Li, SZ; Ohlemiller, KK; Ransohoff, RM | 1 |
| Berlanga Acosta, J; García Del Barco Herrera, D; González Núñez, L; Maza Ares, D; Millares López, R; Rodriguez Salgueiro, S; Santos Febles, E | 1 |
| Grolman, W; Klis, SF; Ramekers, D; Strahl, SB; Versnel, H | 1 |
| Guo, C; Han, Y; Li, H; Peng, B; Peng, XX; Su, YB; Tian, YM | 1 |
| Abbas, L; Rivolta, MN | 1 |
| Chen, Y; Qiao, L; Qiu, J; Wang, Y; Wen, L; Wu, S; Yue, B | 1 |
| Illing, RB; Rauch, AK; Rosskothen-Kuhl, N | 1 |
| Jang, JH; Lee, HS; Oh, SH; Park, MH | 1 |
| Heeringa, AN; Raphael, Y; Shore, SE; Stefanescu, RA | 1 |
| Chabot, N; Clemo, HR; Corley, SB; Lomber, SG; Meredith, MA | 1 |
| Fallon, JB; Irvine, DR; Irving, S; Pannu, SS; Shepherd, RK; Tooker, AC; Wise, AK | 1 |
| Bezdjian, A; Grolman, W; Hendriksen, FG; Klis, SF; van der Linden, CA; Żak, M | 1 |
| Fujii, S; Fujioka, M; Ishimi, Y; Katsumata, S; Takeda, K; Uehara, M | 1 |
| Brown, M; Fallon, JB; Irvine, DR; Shepherd, RK | 1 |
| Cediel, R; Contreras, J; Murillo-Cuesta, S; Varela-Nieto, I | 1 |
| Fan, GR; Huang, X; Kong, WJ; Yang, Y; Yin, ZD | 1 |
| Chen, J; Chen, QG; Chu, HQ; Cui, YH; Huang, XW; Li, JL; Li, ZY; Wang, Y; Xiong, H; Zhou, LQ | 1 |
| Agterberg, MJ; de Groot, JC; Grolman, W; Havenith, S; Klis, SF; Sedee, RJ; Versnel, H | 1 |
| Grolman, W; Klis, SF; Prijs, VF; Stronks, HC; Versnel, H | 1 |
| Hirose, K; Sato, E | 1 |
| Chen, J; Chen, Q; Chu, H; Cui, Y; Huang, X; Li, J; Li, Z; Wang, Y; Xiong, H; Zhou, L; Zhou, X | 1 |
| Han, NR; Jeong, HJ; Kim, HM | 1 |
| Fallon, JB; Landry, TG; Shepherd, RK; Wise, AK | 1 |
| Ge, S; Peng, A; Wang, Q; Wu, W; Xiao, Z; Xie, D | 1 |
| Hampson, AJ; Heffer, LF; Li, J; Millard, RE; Minter, RL; Niasari, A; O'Leary, SJ; Sly, DJ; Winata, L | 1 |
| Illing, RB; Rosskothen-Kuhl, N | 1 |
| Andriankaja, O; Bae, HJ; Bezerra, Bde B; Fine, DH; Graves, DT; Kang, J; Li, Y; Pacios, S; Schreiner, H; Tsiagbe, V | 1 |
| Esser, KH; Gross, G; Hoffmann, A; Lenarz, T; Paasche, G; Reich, U; Sasse, S; Scheper, V; Stöver, T; Warnecke, A; Wenzel, GI; Wissel, K | 1 |
| Kng, W; Yin, Z | 1 |
| Chen, S; Fan, GR; Huang, X; Kong, WJ; Sun, Y; Yin, ZD; Zhang, HL; Zhang, WJ | 1 |
| Agterberg, MJ; de Groot, JC; Grolman, W; Klis, SF; Ramekers, D; van Loon, MC; Versnel, H | 1 |
| Abrams, RM; Antonelli, PJ; Gerhardt, KJ; Huang, X | 1 |
| Abbas, PJ; Hu, N; Miller, CA; Nourski, KV | 1 |
| Clark, G; Hardman, J; O'leary, S; Richardson, R; Wise, AK | 1 |
| Abrashkin, KA; Humayun, N; Lee, VA; Raphael, Y; Rejali, D; Swiderski, DL | 1 |
| Belianin, II; Shmelev, EI | 1 |
| Forge, A; Nevill, G; Taylor, RR | 1 |
| Campbell, S; Forge, A; Hume, CR; Oesterle, EC; Taylor, RR | 1 |
| Fierer, J; Guiney, D; Gunn, JS; Okamoto, S; Woo, H | 1 |
| Han, YC; Hu, YJ; Kong, W; Kong, WJ; Wang, Q; Wang, Y; Xu, L | 1 |
| Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 1 |
| Kuze, F | 1 |
| Nishi, T; Tsuchiya, K | 1 |
| Lally, KP; Nichols, RL | 1 |
| Hartmann, R; Klinke, R; Pfennigdorff, T | 1 |
| Chen, Y; Clark, GM; Shepherd, RK; Xu, SA | 1 |
| Smith, GR; Thornton, EA | 1 |
| Henley, CM; Lonsbury-Martin, B; Martin, GK; Weatherly, RA | 1 |
| Li, D; Pierson, M | 1 |
| Bardakhanova, IP; Il'inskaia, EV | 1 |
| Maĭborodin, IV; Pleshakov, VP; Velichko, IaI | 1 |
| Antonelli, PJ; Dohar, JE; Meixner, KE | 1 |
| Harada, H; Kita, E; Kurioka, T; Yunou, Y | 1 |
| Brown, IW; Hill, GB; Holland, JA; Osterhout, S; Saltzman, HA; Wolfe, WG | 1 |
| Goodman, NL; Otero, RB; Parker, JC | 1 |
| Videau, D | 1 |
| Glassock, RJ; Guze, LB; Harwick, HJ; Kalmanson, GM | 1 |
| Koeda, T; Odaki, M; Sato, K; Yokota, M | 1 |
| Azarova, IA; Golovneva, GP; Mishaeva, NP; Votiakov, VI | 1 |
| Alekseenko, AV; Iftodiĭ, AG; Stoliar, VF | 1 |
| Alekseenko, AV; Iftodiĭ, AG; Seniutovich, RV; Sidorchuk, II | 1 |
| Dougherty, SH | 1 |
| Blackwood, JM; Brown, CS; Lavigne, JE; Machiedo, GW; Rush, BF | 1 |
| Hatala, M; Konícková, L; Prát, V; Ritzerfeld, W | 1 |
| Clark, WW; Pearson, RD; Stebbins, WC; Weiland, NG | 1 |
| Edstrom, LE; Groskin, MG; Krizek, TJ; Robson, MC | 1 |
| Hori, H; Rosoff, CB; Zervas, NT | 1 |
| Bonardi, G; Coppi, G | 1 |
| Afanas'eva, IuP; Makarevich, NM; Mkrtchian, SV | 1 |
| Horai, Z; Matsumura, K; Shimizu, K; Ueda, Y; Yoneda, H | 1 |
| Crifò, S | 1 |
| Nakajo, M; Ogawa, H; Osada, Y | 1 |
| Treppenhauer, HJ | 1 |
| Du Buit, H; Roujeau, J; Worms, R | 1 |
| Cuevas, P; Fine, J; Ishiyama, M; Kaufman, A; Koizumi, S; Woodruff, P | 1 |
| Chamberlain, RE; Das, NK | 1 |
2 review(s) available for kanamycin a and Disease Models, Animal
| Article | Year |
|---|---|
[Research progress of acute kanamycin sulfate-induced deafness in guinea pig].
Topics: Animals; Anti-Bacterial Agents; Cochlea; Deafness; Disease Models, Animal; Ethacrynic Acid; Guinea Pigs; Hair Cells, Auditory; Humans; Kanamycin; Neurons; Spiral Ganglion | 2012 |
Role of amikacin in the management of intra-abdominal sepsis.
Topics: Abdomen; Abscess; Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Kanamycin; Lactams; Peritonitis; Wound Infection | 1985 |
1 trial(s) available for kanamycin a and Disease Models, Animal
| Article | Year |
|---|---|
Role of epidermal growth factor and growth hormone-releasing peptide-6 in acceleration of renal tissue repair after kanamycin overdosing in rats.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Disease Models, Animal; Epidermal Growth Factor; Kanamycin; Kidney; Kidney Tubules, Proximal; Male; Oligopeptides; Rats; Rats, Wistar; Treatment Outcome | 2014 |
88 other study(ies) available for kanamycin a and Disease Models, Animal
| Article | Year |
|---|---|
Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Azabicyclo Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Rats; Structure-Activity Relationship; Tissue Distribution; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2015 |
Genome-wide analysis of fitness factors in uropathogenic Escherichia coli in a pig urinary tract infection model.
Topics: Agar; Animals; Disease Models, Animal; Escherichia coli Infections; Escherichia coli Proteins; Humans; Kanamycin; Lipopolysaccharides; Mice; Swine; Urinary Tract Infections; Uropathogenic Escherichia coli | 2022 |
Refinement of systemic guinea pig deafening in hearing research: Sensorineural hearing loss induced by co-administration of kanamycin and furosemide via the leg veins.
Topics: Animals; Disease Models, Animal; Furosemide; Guinea Pigs; Hair Cells, Auditory; Hearing; Hearing Loss, Sensorineural; Humans; Kanamycin; Spiral Ganglion | 2023 |
Simultaneous rather than retrograde spiral ganglion cell degeneration following ototoxically induced hair cell loss in the guinea pig cochlea.
Topics: Animals; Auditory Threshold; Deafness; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Furosemide; Guinea Pigs; Hair Cells, Auditory; Kanamycin; Nerve Degeneration; Ototoxicity; Spiral Ganglion | 2020 |
Genetic disruption of fractalkine signaling leads to enhanced loss of cochlear afferents following ototoxic or acoustic injury.
Topics: Acoustic Stimulation; Animals; Cell Survival; CX3C Chemokine Receptor 1; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Furosemide; Green Fluorescent Proteins; Hair Cells, Auditory; Hearing Loss, Noise-Induced; Interleukin-1beta; Intermediate Filaments; Kanamycin; Macrophages; Mice; Mice, Inbred C57BL; Mice, Transgenic; Protein Synthesis Inhibitors; Signal Transduction; Spiral Ganglion | 2018 |
The expression of oxidative stress response genes is modulated by a combination of resveratrol and N-acetylcysteine to ameliorate ototoxicity in the rat cochlea.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Auditory Fatigue; Brain Stem; Cochlea; Cytoprotection; Disease Models, Animal; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Furosemide; Gene Expression Regulation; Hearing; Hearing Loss; Inflammation Mediators; Kanamycin; Male; Oxidative Stress; Rats, Wistar; Reaction Time; Resveratrol | 2018 |
The Novel Peptide Vaccine GV1001 Protects Hearing in a Kanamycin-induced Ototoxicity Mouse Model.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Ear, Inner; Hair Cells, Auditory; Hearing; Hearing Loss; Kanamycin; Male; Mice; Peptide Fragments; Telomerase; Vaccines, Subunit | 2018 |
In vivo transcranial flavoprotein autofluorescence imaging of tonotopic map reorganization in the mouse auditory cortex with impaired auditory periphery.
Topics: Acoustic Stimulation; Animals; Auditory Cortex; Auditory Threshold; Brain Mapping; Bumetanide; Disease Models, Animal; Evoked Potentials, Auditory; Female; Flavoproteins; Hearing; Hearing Loss; Kanamycin; Mice, Inbred C57BL; Microscopy, Fluorescence; Neuronal Plasticity; Optical Imaging; Reaction Time; Time Factors | 2019 |
Generation of new hair cells by DNA methyltransferase (Dnmt) inhibitor 5-azacytidine in a chemically-deafened mouse model.
Topics: Animals; Azacitidine; Cochlea; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; Ear, Inner; Enzyme Inhibitors; Furosemide; Hair Cells, Auditory, Inner; Hearing Loss; Humans; Kanamycin; Mice; Regeneration | 2019 |
Deafness induction in mice.
Topics: Animals; Disease Models, Animal; Diuretics; Furosemide; Hair Cells, Auditory; Hearing Loss, Sensorineural; Kanamycin; Mice; Spiral Ganglion | 2013 |
A guinea pig model of selective severe high-frequency hearing loss.
Topics: Action Potentials; Animals; Cochlea; Disease Models, Animal; Furosemide; Guinea Pigs; Hair Cells, Auditory; Hearing; Hearing Loss, High-Frequency; Kanamycin | 2013 |
Therapeutic effect of adeno-associated virus (AAV)-mediated ADNF-9 expression on cochlea of kanamycin-deafened guinea pigs.
Topics: Animals; Cells, Cultured; Cochlea; Deafness; Dependovirus; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Genetic Vectors; Guinea Pigs; Hair Cells, Auditory; Kanamycin; Oligopeptides; Transfection | 2013 |
Kanamycin-furosemide ototoxicity in the mouse cochlea: a 3-dimensional analysis.
Topics: Animals; Cochlea; Cochlear Diseases; Disease Models, Animal; Female; Furosemide; Hair Cells, Auditory; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Injections, Subcutaneous; Kanamycin; Mice; Mice, Inbred CBA; Microscopy, Confocal; Organ of Corti; Radiography; Random Allocation; Reference Values; Sensitivity and Specificity; Ultrasonography | 2014 |
Development of an ototoxicity model in the adult CBA/CaJ mouse and determination of a golden window of corticosteroid intervention for otoprotection.
Topics: Animals; Cell Survival; Dexamethasone; Disease Models, Animal; Furosemide; Hair Cells, Auditory; Kanamycin; Male; Mice, Inbred CBA; Premedication; Time Factors; Translational Research, Biomedical | 2014 |
Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide.
Topics: Animals; Anti-Bacterial Agents; Cochlea; Cochlear Diseases; CX3C Chemokine Receptor 1; Disease Models, Animal; Drug Synergism; Ear, Inner; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hair Cells, Auditory, Outer; Heterozygote; Inflammation; Kanamycin; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Receptors, Chemokine | 2014 |
Local delivery of brain-derived neurotrophic factor on the perforated round window membrane in Guinea pigs: a possible clinical application.
Topics: Animals; Brain-Derived Neurotrophic Factor; Deafness; Disease Models, Animal; Drug Administration Routes; Evoked Potentials, Auditory, Brain Stem; Female; Furosemide; Guinea Pigs; Kanamycin; Round Window, Ear | 2015 |
Recovery characteristics of the electrically stimulated auditory nerve in deafened guinea pigs: relation to neuronal status.
Topics: Animals; Auditory Perception; Cochlear Implantation; Cochlear Nerve; Disease Models, Animal; Electric Stimulation; Evoked Potentials, Auditory; Female; Furosemide; Guinea Pigs; Hearing; Hearing Loss, Sensorineural; Kanamycin; Nerve Degeneration; Perceptual Masking; Reaction Time; Recovery of Function; Refractory Period, Electrophysiological; Spiral Ganglion; Time Factors | 2015 |
Exogenous alanine and/or glucose plus kanamycin kills antibiotic-resistant bacteria.
Topics: Alanine; Animals; Anti-Bacterial Agents; Bacteria; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Glucose; Kanamycin; Metabolomics; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Structure-Activity Relationship; Urinary Tract Infections | 2015 |
Aminoglycoside ototoxicity and hair cell ablation in the adult gerbil: A simple model to study hair cell loss and regeneration.
Topics: Aminoglycosides; Animals; Cochlea; Disease Models, Animal; Female; Gerbillinae; Hair Cells, Auditory, Outer; Hearing; Hearing Loss; Humans; Immunohistochemistry; Kanamycin; Male; Myelin Sheath; Phalloidine; Regeneration; Spiral Ganglion | 2015 |
Establishment of a model of cochlear lesions in rats to study potential gene therapy for sensorineural hearing loss.
Topics: Adenoviridae; Animals; Axons; Cell Death; Disease Models, Animal; Furosemide; Gene Transfer Techniques; Genetic Therapy; Hair Cells, Auditory; Hearing Loss, Sensorineural; Kanamycin; Neurons; Organ of Corti; Rats, Sprague-Dawley; Regeneration; Spiral Ganglion; Transgenes | 2015 |
Counter-regulation of the AP-1 monomers pATF2 and Fos: Molecular readjustment of brainstem neurons in hearing and deaf adult rats after electrical intracochlear stimulation.
Topics: Activating Transcription Factor 2; Animals; Auditory Pathways; Brain Stem; Cochlear Implants; Deafness; Disease Models, Animal; Female; Functional Laterality; Gene Expression; Kanamycin; Neuronal Plasticity; Neurons; Phosphorylation; Proto-Oncogene Proteins c-fos; Rats, Wistar; Sensory Deprivation | 2016 |
Efficacy of the cat deafening method: Co-administration of ethacrynic acid and kanamycin.
Topics: Animals; Cats; Deafness; Disease Models, Animal; Ethacrynic Acid; Kanamycin; Organ of Corti | 2016 |
Altered vesicular glutamate transporter distributions in the mouse cochlear nucleus following cochlear insult.
Topics: Animals; Cell Count; Cochlear Diseases; Cochlear Nucleus; Deafness; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Functional Laterality; Immunohistochemistry; Kanamycin; Mice, Inbred C57BL; Neurons; Spiral Ganglion; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2 | 2016 |
Cortical and thalamic connectivity of the auditory anterior ectosylvian cortex of early-deaf cats: Implications for neural mechanisms of crossmodal plasticity.
Topics: Acoustic Stimulation; Adaptation, Physiological; Age Factors; Animals; Auditory Cortex; Auditory Pathways; Auditory Perception; Cats; Disease Models, Animal; Hearing; Hearing Loss; Kanamycin; Neuroanatomical Tract-Tracing Techniques; Neuronal Plasticity; Photic Stimulation; Thalamus; Visual Cortex; Visual Perception | 2016 |
Second spatial derivative analysis of cortical surface potentials recorded in cat primary auditory cortex using thin film surface arrays: Comparisons with multi-unit data.
Topics: Acoustic Stimulation; Animals; Auditory Cortex; Auditory Perception; Cats; Cochlear Implants; Deafness; Disease Models, Animal; Electrodes, Implanted; Equipment Design; Evoked Potentials, Auditory; Kanamycin; Signal Processing, Computer-Assisted | 2016 |
Scar formation in mice deafened with kanamycin and furosemide.
Topics: Animals; Disease Models, Animal; Furosemide; Hair Cells, Auditory; Hearing Loss, Sensorineural; Kanamycin; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Organ of Corti | 2016 |
Kanamycin inhibits daidzein metabolism and abilities of the metabolites to prevent bone loss in ovariectomized mice.
Topics: Administration, Oral; Animals; Biotransformation; Body Weight; Bone Density; Diet; Disease Models, Animal; Equol; Female; Femur; Humans; Isoflavones; Kanamycin; Mice; Organ Size; Osteoporosis; Ovariectomy; Phytoestrogens; Uterus | 2016 |
Effects of neonatal partial deafness and chronic intracochlear electrical stimulation on auditory and electrical response characteristics in primary auditory cortex.
Topics: Acoustic Stimulation; Age Factors; Aging; Animals; Animals, Newborn; Auditory Cortex; Auditory Perception; Auditory Threshold; Cats; Cochlear Implantation; Cochlear Implants; Disease Models, Animal; Electric Stimulation; Ethacrynic Acid; Evoked Potentials, Auditory; Hearing Loss, High-Frequency; Kanamycin; Neuronal Plasticity; Reaction Time; Time Factors | 2009 |
Comparison of different aminoglycoside antibiotic treatments to refine ototoxicity studies in adult mice.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Cochlea; Disease Models, Animal; Dose-Response Relationship, Drug; Evoked Potentials, Auditory, Brain Stem; Gentamicins; Hearing Loss; Kanamycin; Male; Mice; Mice, Inbred C57BL; Mortality; Neomycin | 2010 |
Time course of neuronal and synaptic plasticity in dorsal cochlear nucleus of guinea pig following chronic kanamycin-induced deafness.
Topics: Animals; Auditory Threshold; Cochlear Nerve; Cochlear Nucleus; Deafness; Disease Models, Animal; Guinea Pigs; Hearing; Insulin-Like Growth Factor I; Kanamycin; Neuronal Plasticity; Neurotoxins; Presynaptic Terminals; Recovery of Function; RNA, Messenger; Synapses; Synaptic Transmission; Time Factors; Up-Regulation | 2010 |
[Rapid cochlea lesion induced by co-administration of kanamycin and furosemide in mouse].
Topics: Animals; Cell Death; Cochlea; Disease Models, Animal; Drug Synergism; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hair Cells, Auditory; Kanamycin; Mice; Mice, Inbred CBA | 2010 |
Spiral ganglion cell survival after round window membrane application of brain-derived neurotrophic factor using gelfoam as carrier.
Topics: Acoustic Stimulation; Animals; Auditory Threshold; Brain-Derived Neurotrophic Factor; Cell Shape; Cell Size; Cell Survival; Disease Models, Animal; Drug Carriers; Electric Stimulation; Evoked Potentials, Auditory, Brain Stem; Female; Furosemide; Gelatin Sponge, Absorbable; Guinea Pigs; Hearing Loss; Kanamycin; Neuroprotective Agents; Spiral Ganglion; Time Factors | 2011 |
Effects of electrical stimulation on the acoustically evoked auditory-nerve response in guinea pigs with a high-frequency hearing loss.
Topics: Acoustic Stimulation; Animals; Auditory Threshold; Cochlea; Cochlear Implantation; Cochlear Microphonic Potentials; Cochlear Nerve; Disease Models, Animal; Female; Furosemide; Guinea Pigs; Hearing Loss, High-Frequency; Kanamycin; Time Factors | 2011 |
Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea.
Topics: Acoustic Stimulation; Animals; Atrophy; Auditory Threshold; Cell Death; Cell Movement; Cochlea; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hair Cells, Auditory, Outer; Hearing Loss; Kanamycin; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes | 2011 |
Conservation of endocochlear potential in mice with profound hearing loss induced by co-administration of kanamycin and furosemide.
Topics: Animals; Anti-Bacterial Agents; Auditory Threshold; Cell Death; Cell Survival; Cochlea; Cochlear Microphonic Potentials; Disease Models, Animal; Diuretics; Drug Combinations; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hair Cells, Auditory, Inner; Hair Cells, Auditory, Outer; Hearing Loss; Kanamycin; Male; Mice; Mice, Inbred CBA; Protein Synthesis Inhibitors; Stria Vascularis; Time Factors | 2011 |
Kanamycin activates caspase-1 in NC/Nga mice.
Topics: Animals; Anti-Bacterial Agents; Caspase 1; Dermatitis, Atopic; Disease Models, Animal; Histamine; I-kappa B Proteins; Immunoglobulin E; Interleukin-18; Interleukin-1beta; Kanamycin; Male; Mice; Mice, Inbred Strains; NF-kappa B; NF-KappaB Inhibitor alpha; Skin; Tumor Necrosis Factor-alpha | 2011 |
Spiral ganglion neuron survival and function in the deafened cochlea following chronic neurotrophic treatment.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Auditory Threshold; Brain-Derived Neurotrophic Factor; Cell Proliferation; Cell Survival; Cochlea; Cochlear Implantation; Cytoprotection; Deafness; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Female; Guinea Pigs; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Kanamycin; Male; Neurogenesis; Neurons; Neurotrophin 3; Recombinant Proteins; Spiral Ganglion; Time Factors | 2011 |
[Expression of TMPRSS3 in the rat cochlea following kanamycin ototoxicity].
Topics: Animals; Anti-Bacterial Agents; Cochlea; Deafness; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Kanamycin; Male; Membrane Proteins; Rats; Rats, Sprague-Dawley; Serine Endopeptidases | 2011 |
Brain-derived neurotrophic factor modulates auditory function in the hearing cochlea.
Topics: Animals; Auditory Threshold; Brain-Derived Neurotrophic Factor; Cell Survival; Deafness; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Female; Guinea Pigs; Hearing; Infusion Pumps; Kanamycin; Male; Otoacoustic Emissions, Spontaneous; Protein Synthesis Inhibitors; Round Window, Ear; Spiral Ganglion | 2012 |
The impact of hearing experience on signal integration in the auditory brainstem: a c-Fos study of the rat.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Animals, Newborn; Auditory Threshold; Cochlea; Cochlear Implants; Cochlear Nucleus; Deafness; Disease Models, Animal; Electric Stimulation; Female; Functional Laterality; Gene Expression Regulation; Inferior Colliculi; Kanamycin; Male; Neurons; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Time Factors | 2012 |
A.actinomycetemcomitans-induced periodontal disease promotes systemic and local responses in rat periodontium.
Topics: Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Alveolar Bone Loss; Ampicillin; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; CD8-Positive T-Lymphocytes; Chemotaxis, Leukocyte; Disease Models, Animal; Epithelial Attachment; Kanamycin; Monocytes; Neutrophil Activation; Osteoclasts; Periodontal Attachment Loss; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2012 |
Stable release of BDNF from the fibroblast cell line NIH3T3 grown on silicone elastomers enhances survival of spiral ganglion cells in vitro and in vivo.
Topics: Animals; Animals, Newborn; Brain-Derived Neurotrophic Factor; Cell Adhesion; Cell Culture Techniques; Cell Proliferation; Cell Survival; Coculture Techniques; Deafness; Disease Models, Animal; Ethacrynic Acid; Female; Fibroblasts; Genetic Vectors; Green Fluorescent Proteins; Guinea Pigs; Humans; Kanamycin; Lentivirus; Male; Mice; Neurons; NIH 3T3 Cells; Paracrine Communication; Rats; Rats, Sprague-Dawley; Silicone Elastomers; Spiral Ganglion; Time Factors; Transfection | 2012 |
Reversible neurotoxicity of kanamycin on dorsal cochlear nucleus.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Apoptosis; Apoptosis Regulatory Proteins; Beclin-1; Body Weight; Cell Count; Cochlear Nucleus; Creatinine; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Gene Expression Regulation; In Situ Nick-End Labeling; Kanamycin; Kidney; Male; Microscopy, Electron, Transmission; Mitogen-Activated Protein Kinase 8; Nerve Tissue Proteins; Neurons; Neurotoxicity Syndromes; Nitrogen; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors | 2013 |
Spiral ganglion cell morphology in guinea pigs after deafening and neurotrophic treatment.
Topics: Animals; Auditory Threshold; Brain-Derived Neurotrophic Factor; Cell Shape; Cell Size; Cell Survival; Deafness; Disease Models, Animal; Female; Furosemide; Ganglia, Spinal; Guinea Pigs; Hair Cells, Auditory; Kanamycin; Nerve Degeneration; Neurons; Time Factors | 2013 |
Fetal central auditory system metabolic response to cochlear implant stimulation.
Topics: Animals; Anti-Bacterial Agents; Auditory Diseases, Central; Autoradiography; Brain Chemistry; Carbon Radioisotopes; Cochlear Implantation; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Fetal Diseases; Gestational Age; Humans; Infant, Newborn; Kanamycin; Microscopy, Electron, Scanning; Neonatal Screening; Prenatal Care; Sheep | 2002 |
Co-administration of kanamycin and ethacrynic acid as a deafening method for acute animal experiments.
Topics: Animals; Deafness; Disease Models, Animal; Drug Synergism; Ethacrynic Acid; Guinea Pigs; Kanamycin | 2004 |
Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Count; Cell Survival; Cochlea; Cochlear Implantation; Deafness; Disease Models, Animal; Furosemide; GAP-43 Protein; Guinea Pigs; Immunohistochemistry; Kanamycin; Models, Biological; Nerve Degeneration; Nerve Regeneration; Neurofilament Proteins; Neurons, Afferent; Neurotrophin 3; Time Factors | 2005 |
Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.
Topics: Adenoviridae; Animals; Brain-Derived Neurotrophic Factor; Cell Survival; Cells, Cultured; Cochlear Implantation; Cochlear Implants; Deafness; Disease Models, Animal; Ethacrynic Acid; Feasibility Studies; Fibroblasts; Genetic Therapy; Genetic Vectors; Guinea Pigs; Kanamycin; Nerve Degeneration; Neurons; Prosthesis Design; Sepharose; Spiral Ganglion; Transduction, Genetic | 2007 |
[Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Mice; Mice, Inbred BALB C; Middle Aged; Mycobacterium tuberculosis; Ozone; Radiography, Thoracic; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
Rapid hair cell loss: a mouse model for cochlear lesions.
Topics: Age Factors; Amikacin; Animals; Anti-Bacterial Agents; Bumetanide; Cell Death; Cell Survival; Cochlear Diseases; Disease Models, Animal; Diuretics; Fluorescent Dyes; Gentamicins; Hair Cells, Auditory, Outer; Kanamycin; Mice; Mice, Inbred CBA; Pyridinium Compounds; Quaternary Ammonium Compounds; Stria Vascularis | 2008 |
Sox2 and JAGGED1 expression in normal and drug-damaged adult mouse inner ear.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Biomarkers; Calcium-Binding Proteins; Chickens; Cochlear Diseases; Disease Models, Animal; Diuretics; Furosemide; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Kanamycin; Membrane Proteins; Mice; Mice, Inbred CBA; Organ of Corti; Serrate-Jagged Proteins; SOXB1 Transcription Factors; Time Factors | 2008 |
A model of Salmonella colitis with features of diarrhea in SLC11A1 wild-type mice.
Topics: Animals; Cation Transport Proteins; Colitis; Colon; Diarrhea; Disease Models, Animal; Disease Susceptibility; Kanamycin; Membrane Glycoproteins; Mice; NADPH Oxidase 2; NADPH Oxidases; Salmonella Infections, Animal; Salmonella typhimurium | 2008 |
[Sensitivity to the ototoxicity of kanamycin of the rat model for mimetic aging in the inner ear].
Topics: Aging, Premature; Animals; Disease Models, Animal; Disease Susceptibility; DNA, Mitochondrial; Ear, Inner; Galactose; Kanamycin; Rats; Rats, Wistar; Sequence Deletion | 2008 |
Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Cefoxitin; Ceftizoxime; Disease Models, Animal; Drug Combinations; Female; Hydrogen-Ion Concentration; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillins; Protein Binding; Pseudomonas Infections; Rabbits | 1984 |
Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice.
Topics: Animals; Antitubercular Agents; Chronic Disease; Cycloserine; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Kanamycin; Liver; Lung; Male; Mice; Mycobacterium avium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Spleen; Time Factors | 1984 |
Therapeutic effects of cefotiam and cefazolin on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.
Topics: Animals; Cefazolin; Cefotiam; Cephalosporins; Disease Models, Animal; Drug Administration Schedule; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Pneumonia | 1980 |
Various intraperitoneal irrigation solutions in treating experimental fecal peritonitis.
Topics: Animals; Disease Models, Animal; Feces; Humans; Kanamycin; Male; Peritonitis; Povidone-Iodine; Rats; Sodium Chloride; Therapeutic Irrigation | 1981 |
Evoked potentials from the auditory nerve following sinusoidal electrical stimulation of the cochlea: new possibilities for preoperative testing in cochlear-implant candidates?
Topics: Acoustic Stimulation; Action Potentials; Animals; Artifacts; Cats; Cochlea; Cochlear Implants; Deafness; Disease Models, Animal; Electric Stimulation; Ethacrynic Acid; Evoked Potentials, Auditory, Brain Stem; Humans; Kanamycin; Neomycin; Vestibulocochlear Nerve | 1994 |
Profound hearing loss in the cat following the single co-administration of kanamycin and ethacrynic acid.
Topics: Animals; Cats; Cochlea; Deafness; Dendrites; Disease Models, Animal; Dose-Response Relationship, Drug; Ethacrynic Acid; Evoked Potentials, Auditory, Brain Stem; Hair Cells, Auditory; Kanamycin; Kidney; Organ of Corti; Spiral Ganglion | 1993 |
Effect of disturbance of the gastrointestinal microflora on the faecal excretion of Fusobacterium necrophorum biovar A.
Topics: Animals; Bacteria; Digestive System; Disease Models, Animal; Erythromycin; Feces; Female; Fusobacterium Infections; Fusobacterium necrophorum; Kanamycin; Metronidazole; Mice; Phenotype | 1993 |
Sensitive developmental periods for kanamycin ototoxic effects on distortion-product otoacoustic emissions.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hair Cells, Auditory, Outer; Kanamycin; Otoacoustic Emissions, Spontaneous; Pregnancy; Rats | 1996 |
Cochlear integrity in rats with experimentally induced audiogenic seizure susceptibility.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Cochlea; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Hair Cells, Auditory, Inner; Hair Cells, Auditory, Outer; Hearing Loss, Noise-Induced; Kanamycin; Noise; Rats; Rats, Wistar; Regression Analysis | 1996 |
[Ultrastructural changes in the neurosensory epithelium of the cochlea under the influence of electrostimulation].
Topics: Animals; Anti-Bacterial Agents; Cochlea; Disease Models, Animal; Electric Stimulation; Epithelial Cells; Guinea Pigs; Hearing Loss, Sensorineural; Kanamycin; Microscopy, Electron; Time Factors | 1998 |
[Structural formation of adhesions in abdominal cavity and bowel walls in treatment of peritonitis by sorbent with absorbed metrinidazole or lipoorizinum (experimental study)].
Topics: Abdomen; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Colon; Disease Models, Animal; Drug Combinations; Enzyme Therapy; Follow-Up Studies; Kanamycin; Leukocyte Count; Male; Metronidazole; Peritonitis; Rats; Rats, Wistar; Sorption Detoxification; Suppuration; Tissue Adhesions; Treatment Outcome | 1999 |
The effects of kanamycin injection into the fetal lamb cochlea.
Topics: Animals; Anti-Bacterial Agents; Audiometry; Cochlea; Disease Models, Animal; Female; Hair Cells, Auditory, Inner; Hearing Loss, Sensorineural; Injections, Intralesional; Kanamycin; Pregnancy; Reference Values; Sheep; Temporal Bone | 1999 |
Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Toxins; Brain Chemistry; Disease Models, Animal; Disease Progression; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Kanamycin; Mice; Mice, Inbred C57BL; Norfloxacin; Protein-Energy Malnutrition; Reference Values; Sensitivity and Specificity; Shiga Toxins; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
Experimental and clinical experience with hyperbaric oxygen in the treatment of clostridial myonecrosis.
Topics: Adult; Amputation, Surgical; Antitoxins; Bacteroides Infections; Cephalothin; Clindamycin; Clostridium perfringens; Debridement; Disease Models, Animal; Evaluation Studies as Topic; Female; Gas Gangrene; Gentamicins; Humans; Hyperbaric Oxygenation; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Resuscitation; Surgical Wound Infection; Wound Infection | 1975 |
Predisposing factors in systemic and central nervous system candidiasis: histopathological and cultural observations in the rat.
Topics: Animals; Brain; Candida albicans; Candidiasis; Cortisone; Disease Models, Animal; Kanamycin; Organ Specificity; Rats; Tetracycline | 1978 |
[Experimental pyelonephritis in rats: value in the comparison of antibiotics (author's transl)].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cefazolin; Cephaloridine; Cephalothin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Female; Injections, Intramuscular; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Nalidixic Acid; Nitroquinolines; Pyelonephritis; Rats; Rifampin; Sulfamethoxypyridazine; Urine | 1976 |
Cellular immunity in experimental pyelonephritis.
Topics: Animals; Antigens, Bacterial; Cell Migration Inhibition; Disease Models, Animal; Enterococcus faecalis; Female; Immunity, Cellular; Kanamycin; Kidney; Male; Parabiosis; Penicillin G Benzathine; Pyelonephritis; Rats; Rats, Inbred Strains; Streptococcal Infections | 1975 |
[Ototoxic effects of some aminoglycoside antibiotics on the inner ear in the spontaneously hypertensive rats (SHR) (author's transl)].
Topics: Animals; Anti-Bacterial Agents; Body Weight; Dibekacin; Disease Models, Animal; Ear, Inner; Gentamicins; Hypertension; Injections, Intramuscular; Kanamycin; Male; Rats; Ribostamycin; Tissue Distribution | 1977 |
[Search for inhibitors of West Nile virus among antibiotics].
Topics: Animals; Antiviral Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Gentamicins; Kanamycin; Mice; West Nile Fever; West Nile virus | 1992 |
[Galvanic current in the conservative treatment of acute pancreatitis].
Topics: Acute Disease; Animals; Disease Models, Animal; Dogs; Female; Humans; Iontophoresis; Kanamycin; Male; Pancreas; Pancreatitis | 1990 |
[Optimization of the antibiotic therapy in treating acute complicated cholecystitis].
Topics: Acute Disease; Aged; Animals; Anti-Bacterial Agents; Bile; Cholecystitis; Combined Modality Therapy; Disease Models, Animal; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Female; Humans; Iontophoresis; Kanamycin; Kinetics; Liver; Male; Middle Aged; Postoperative Care; Time Factors | 1985 |
The treatment of experimental peritonitis with intraperitoneal betadine solution.
Topics: Absorption; Animals; Cephalothin; Disease Models, Animal; Escherichia coli Infections; Injections, Intraperitoneal; Iodine; Kanamycin; Peritonitis; Povidone; Povidone-Iodine; Rats; Thyroid Function Tests; Tissue Adhesions | 1974 |
[Models of urinary infection].
Topics: Animals; Bacterial Infections; Bacteriuria; Carbenicillin; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Gentamicins; Kanamycin; Kidney; Mice; Nitrofurantoin; Pseudomonas; Pseudomonas Infections; Pyelonephritis; Rabbits; Rats; Sulfadiazine; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 1974 |
Noise-and drug-induced hearing loss in monkeys.
Topics: Acoustic Stimulation; Animals; Auditory Threshold; Conditioning, Operant; Deafness; Disease Models, Animal; Haplorhini; Hearing Loss, Noise-Induced; Kanamycin; Macaca; Methods; Neomycin; Papio; Quinidine; Sodium Salicylate; Time Factors | 1973 |
The efficacy of systemic antibiotics in the treatment of granulating wounds.
Topics: Animals; Anti-Bacterial Agents; Burns; Cephalexin; Cephaloridine; Cephalothin; Disease Models, Animal; Escherichia coli Infections; Granulation Tissue; Kanamycin; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Staphylococcal Infections; Wounds and Injuries | 1974 |
Experimental inhibition of serotonin by antibiotic: prevention of cerebral vasospasm.
Topics: Animals; Cerebral Angiography; Disease Models, Animal; Evaluation Studies as Topic; Haplorhini; Ischemic Attack, Transient; Kanamycin; Macaca; Pyridoxine; Reserpine; Serotonin; Serotonin Antagonists; Subarachnoid Hemorrhage | 1974 |
Urease-inhibiting action of some drugs in vitro and in vivo.
Topics: Ammonia; Animals; Anti-Bacterial Agents; Ascorbic Acid; Bacitracin; Chloramphenicol; Chlortetracycline; Demeclocycline; Depression, Chemical; Disease Models, Animal; Enzyme Repression; Erythromycin; Female; Hydroxamic Acids; In Vitro Techniques; Intestines; Kanamycin; Male; Neomycin; Niacinamide; Oxytetracycline; Penicillin G; Rats; Streptomycin; Sulfamethoxypyridazine; Sulfisoxazole; Sulfonamides; Tetracycline; Urease | 1970 |
[Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
Topics: Animals; Disease Models, Animal; Drug Resistance, Microbial; In Vitro Techniques; Kanamycin; Methods; Mice; Mycobacterium tuberculosis; Streptomycin; Tuberculosis; Viomycin | 1970 |
[Induction of Mycobacterium infection by introduction of the organisms into the lung through an intratracheal vinyl tube].
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Dust; Ethambutol; Guinea Pigs; Intubation, Intratracheal; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Silicon Dioxide; Tuberculosis, Pulmonary | 1972 |
Identification of ototoxic drugs by guinea pig shiver audiometry.
Topics: Animals; Audiometry; Auditory Threshold; Avoidance Learning; Deafness; Disease Models, Animal; Drug Evaluation, Preclinical; Ear; Ear Diseases; Electroshock; Ethacrynic Acid; Female; Guinea Pigs; Kanamycin; Male; Organ of Corti; Shivering; Sodium; Sulfates | 1974 |
Application of experimental keratoconjunctivitis shigellosa in chemotherapeutic evaluation of rifampicin to bacillary dysentery.
Topics: Animals; Cornea; Disease Models, Animal; Dysentery, Bacillary; Epithelial Cells; Escherichia coli; Evaluation Studies as Topic; Guinea Pigs; Injections, Intramuscular; Kanamycin; Keratoconjunctivitis; Ophthalmic Solutions; Rifampin; Shigella; Shigella flexneri; Streptomycin; Tetracycline | 1972 |
[Comparative toxicological, bacteriological and pharmacokinetic studies on Kanamycin].
Topics: Animals; Bacteria; Cattle; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; Kanamycin; Mice; Microbial Sensitivity Tests | 1973 |
The effect of a foreign body on the histological response to staphylococcic infection.
Topics: Animals; Disease Models, Animal; Femoral Fractures; Femur; Foreign Bodies; Fracture Fixation; Guinea Pigs; Hair; Horses; Humans; Kanamycin; Lincomycin; Male; Staphylococcal Infections; Staphylococcus; Testis | 1973 |
Role of endotoxemia of intestinal origin in early death from large burns.
Topics: Animals; Aorta; Blood Volume; Burns; Disease Models, Animal; Endotoxins; Intestinal Absorption; Intestinal Diseases; Kanamycin; Kidney; Liver; Lung; Methylprednisolone; Plasma Volume; Pseudomonas Infections; Rabbits; Shock, Septic; Sodium Chloride; Spleen; Sulfonamides; Tosyl Compounds; Toxemia; Veins | 1974 |
Chemotherapy of mice experimentally infected with Shigella flexneri.
Topics: Administration, Oral; Ampicillin; Animals; Antibodies; Colistin; Disease Models, Animal; Dysentery, Bacillary; Feces; Hemagglutination Tests; Intestines; Kanamycin; Lymph Nodes; Male; Mesentery; Mice; Neomycin; Oxytetracycline; Shigella | 1970 |